Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature

INTRODUCTION: Inherent and acquired cisplatin resistance reduces the effectiveness of this agent in the management of non-small cell lung cancer (NSCLC). Understanding the molecular mechanisms underlying this process may result in the development of novel agents to enhance the sensitivity of cisplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Barr, Martin P., Gray, Steven G., Hoffmann, Andreas C., Hilger, Ralf A., Thomale, Juergen, O’Flaherty, John D., Fennell, Dean A., Richard, Derek, O’Leary, John J., O’Byrne, Kenneth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547914/
https://www.ncbi.nlm.nih.gov/pubmed/23349823
http://dx.doi.org/10.1371/journal.pone.0054193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547914/
https://www.ncbi.nlm.nih.gov/pubmed/23349823
http://dx.doi.org/10.1371/journal.pone.0054193

Ejemplares similares